DAC comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-07-28. Where a claim depends on a specific study, the study is described rather than over-claimed.
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
| Property | Value | Notes |
|---|---|---|
| Appearance as powder | White to off-white solid | Minor batch-to-batch variation is normal |
| Solubility class | Soluble in water and aqueous buffers | Dissolution can be slowed by aggregates |
| Typical storage temperature | Minus 20 degrees Celsius or below | Protected from light and moisture |
| Storage after reconstitution | 2 to 8 degrees Celsius, short term | Longer holding requires freezing |
| Common analytical method | Reversed-phase HPLC with mass spectrometry | Used for purity and identity confirmation |
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Though it became a "forgotten drug" following the discovery of antibiotics in 1928, there has been a resurgence in interest in methenamine since 2010 owing to increasing rates of bacterial resistance with antibiotics. Larger and higher-quality clinical trials of methenamine for UTI prevention have started to be published in the 2020s and it may soon be recommended by more medical guidelines. Methenamine has been found to be more cost-effective than low-dose prophylactic antibiotics for preventing UTIs.
== Career == From 1967 to 1972, Chrestensen served as production manager of his family's horticultural business in Erfurt. The firm was subsequently nationalized, and from 1972 to 1990 he worked as production manager of the East German state enterprise VEB Erfurter Blumensamen.Following German reunification, from 1990 to 2010 he served as co-managing director of the reconstituted Erfurt seed and plant-breeding company N. L. Chrestensen. From 1990 to 2010, Chrestensen also served as president of the Thuringian Chamber of Industry and Commerce (Industrie- und Handelskammer Thüringen). In that role, he was a co-founder of the Erfurt chamber of commerce after reunification and advocated for Erfurt's inclusion as a stop on Germany's Intercity-Express (ICE) high-speed rail network.
A Drugscope survey of drug workers at the end of 2012 reported that mephedrone use was still widespread in the UK and that there were increasing reports of problematic users. It was being taken as not only a "poor man's cocaine" but also amongst users of heroin and crack cocaine. Cases of intravenous use were also reported to be on the increase.
Protactinium(V) bromide has two similar monoclinic forms: one is obtained by sublimation at 400–410 °C, and another by sublimation at a slightly lower temperature of 390–400 °C. Protactinium iodides can be produced by reacting protactinium metal with elemental iodine at 600 °C, and by reacting Pa2O5 with AlI3 at elevated temperatures. Protactinium(III) iodide can be obtained by heating protactinium(V) iodide in vacuum. As with oxides, protactinium forms mixed halides with alkali metals. The most remarkable among these is Na3PaF8, where the protactinium ion is symmetrically surrounded by 8 F− ions, forming a nearly perfect cube. More complex protactinium fluorides are also known, such as Pa2F9 and ternary fluorides of the types MPaF6 (M = Li, Na, K, Rb, Cs or NH4), M2PaF7 (M = K, Rb, Cs or NH4), and M3PaF8 (M = Li, Na, Rb, Cs), all of which are white crystalline solids. The MPaF6 formula can be represented as a combination of MF and PaF5. These compounds can be obtained by evaporating a hydrofluoric acid solution containing both complexes. For the small alkali cations like Na, the crystal structure is tetragonal, whereas it becomes orthorhombic for larger cations K+, Rb+, Cs+ or NH4+. A similar variation was observed for the M2PaF7 fluorides: namely, the crystal symmetry was dependent on the cation and differed for Cs2PaF7 and M2PaF7 (M = K, Rb or NH4).
Sources: en.wikipedia.org
== Amino acid specificity == Many different amino acid side chains have been described as ADP-ribose acceptors. From a chemical perspective, this modification represents protein glycosylation: the transfer of ADP-ribose occurs onto amino acid side chains with a nucleophilic oxygen, nitrogen, or sulfur, resulting in N-, O-, or S-glycosidic linkage to the ribose of the ADP-ribose. Originally, acidic amino acids (glutamate and aspartate) were described as the main sites of ADP-ribosylation. However, many other ADP-ribose acceptor sites such as serine, arginine, cysteine, lysine, diphthamide, phosphoserine, and asparagine have been identified in subsequent works.
The LCD panel is designed for medical equipment and professional video equipment. On October 25, 2012, LG Electronics began selling the first flat panel Ultra HD display in the United States with a resolution of 3840 × 2160. The LG 84LM9600 is an 84 in (210 cm) flat panel LED-backlit LCD with a price of US$19,999 though the retail store was selling it for US$16,999. On November 29, 2012, Sony announced the 4K Ultra HD Video Player—a hard disk server preloaded with ten 4K movies and several 4K video clips that they planned to include with the Sony XBR-84X900. The preloaded 4K movies are The Amazing Spider-Man, Total Recall (2012), The Karate Kid (2010), Salt, Battle: Los Angeles, The Other Guys, Bad Teacher, That's My Boy, Taxi Driver, and The Bridge on the River Kwai. Additional 4K movies and 4K video clips will be offered for the 4K Ultra HD Video Player in the future. On November 30, 2012, Red Digital Cinema Camera Company announced that they were taking pre-orders for the US$1,450 REDRAY 4K Cinema Player, which can output 4K resolution to a single 4K display or to four 1080p displays arranged in any configuration via four HDMI 1.4 connections. Video output can be DCI 4K (4096 × 2160), 4K Ultra HD, 1080p, and 720p at frame rates of up to 60 fps with a color depth of up to 12 bpc with 4:2:2 chroma subsampling. Audio output can be up to 7.1 channels. Content is distributed online using the ODEMAX video service. External storage can be connected using eSATA, Ethernet, USB, or a Secure Digital memory card.
==== MeSH D12.125.067 – amino acids, acidic ==== MeSH D12.125.067.500 – aspartic acid MeSH D12.125.067.500.150 – d-aspartic acid MeSH D12.125.067.500.275 – isoaspartic acid MeSH D12.125.067.500.400 – n-methylaspartate MeSH D12.125.067.500.700 – potassium magnesium aspartate MeSH D12.125.067.750 – glutamic acid MeSH D12.125.067.750.150 – 1-carboxyglutamic acid MeSH D12.125.067.750.400 – glutamates MeSH D12.125.067.750.400.700 – polyglutamic acid MeSH D12.125.067.750.400.800 – sodium glutamate MeSH D12.125.067.750.700 – pyrrolidonecarboxylic acid
Herbal teas or herb teas, technically known as herbal infusions and less commonly called tisanes, are beverages made from the infusion or decoction in water of any herbs, spices, or other plant material (except tea leaves). Many herbs used in teas/tisanes are also used in herbal medicine and in folk medicine. Herbal teas are not technically a tea because they are not brewed from the tea plant (Camellia sinensis). The term "herbal tea" is often used to distinguish these infusions from true teas (e.g., black, green, white, yellow, oolong). Blended teas include material from other plants, such as in jasmine tea, genmaicha, and Earl Grey tea. Unlike true teas, most tisanes do not naturally contain caffeine (though tea can be decaffeinated, i.e., processed to remove caffeine). A number of plants, however, do contain psychoactive compounds, such as caffeine or another stimulant, like theobromine, cocaine or ephedrine. Some have the opposite effect, acting as a sedative. Some common infusions have specific names such as mate (yerba mate) and rooibos (red bush).
For an odd-numbered saturated fat (Cn), 0.5 * n - 1.5 oxidations are necessary, and the final process yields 8 acetyl CoA and 1 propionyl CoA. It is then converted to a succinyl CoA by a carboxylation reaction and generates additional 5 ATP (1 ATP is consumed in carboxylation process generating a net of 4 ATP). In addition, two equivalents of ATP are lost during the activation of the fatty acid. Therefore, the total ATP yield can be stated as:
Sources: en.wikipedia.org
Chromatography reports how much material elutes as a single peak but does not confirm what that material is. Mass spectrometry supplies the molecular mass, which is characteristic of a given sequence and its modifications. Together the two methods support both a purity figure and an identity claim.
Hydrolysis, oxidation of susceptible residues, and aggregation all contribute, and their rates depend on pH, temperature, and concentration. Dissolved oxygen and trace metal ions accelerate oxidation. Keeping solutions cold, dilute, and free of unnecessary handling reduces these pathways.
Not always, because the value depends on the detection wavelength, the gradient, and how peak areas are integrated. A figure of ninety-eight percent from one laboratory may not mean the same as the same number from another. Comparing full chromatograms and mass spectra is more informative than comparing a single number.
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.